ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Mol Pharm Org Process Res 2023, Vol 11(3): 174

Changes in Erythropoiesis in Type 3 Hemochromatosis Mouse Models

Ramos Sousa*
Department of Clinical and Biological Sciences, AOU San Luigi Gonzaga, University of Torino, California, USA
*Corresponding Author : Ramos Sousa, Department of Clinical and Biological Sciences, AOU San Luigi Gonzaga, University of Torino, California, USA, Email: ramos.sousa@gamil.com

Received Date: May 01, 2023 / Published Date: May 29, 2023

Abstract

Type 3 haemochromatosis is a rare inherited iron excess condition that results in organ dysfunction. Mutations in the transferrin receptor 2 gene, which codes for two major isoforms, cause HFE3. Tfr2 is a hepatic regulator of the iron inhibitor hepcidin. Tfr2 is an intracellular isoform of the protein that controls iron levels in reticuloendothelial cells. Tfr2 is also important in erythropoiesis, as recently revealed. Tfr2 deficiency causes macrocytosis with reduced reticulocyte number and higher haemoglobin levels, as well as an increase in adult BM erythropoiesis and splenic erythropoiesis. Tfr2 deficiency, on the other hand, results in enhanced and immature splenic erythropoiesis. Taken together, our findings support the involvement of Tfr2 in erythropoiesis regulation and Tfr2 in promoting iron availability for erythropoiesis.

Citation: Sousa R (2023) Changes in Erythropoiesis in Type 3 Hemochromatosis Mouse Models. J Mol Pharm Org Process Res 11: 174.

Copyright: © 2023 Sousa R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top